PHASERX, INC.
DelistedCIK 1429386fmd_03WN09QSF7RBZR0RZ5JWKKPCB8Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Sep 30, 2017, 10 periods
| Line item | FY2015 | FY2016 |
|---|---|---|
| Research and development | 5 | 7 |
| Total operating expenses | 6 | 18 |
| Operating income | (6) | (18) |
| Interest expense | 2 | 2 |
| Interest and investment income | 0 | 0 |
| Other non-operating income (expense) | (2) | (2) |
| Income tax expense | 0 | 0 |
| Net income | (7) | (20) |